Research ID
hum0513-v1Release info
Research title
Immune profiling study of COVID-19 vaccine recipients
Research overview
- Aims
- To comprehensively analyze antibodies and immune cells in individuals who received approved COVID-19 vaccines in Japan and to identify factors correlated with vaccine efficacy, adverse reactions, and adverse events.
- Methods
- scRNA-seq, scTCR-seq
- Participants/materials
- 14 Healthy donors who received COVID-19 vaccines
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000937 | NGS (scRNA-seq, scTCR-seq) |
| Controlled-access (Type I) | 2026-09-08 |
Data provider
- Principal investigator
- Yoshimasa Takahashi
- Affiliation
- Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST) | Evolution of humoral immune memory for resisting viral escape |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Antibody durability is influenced by interleukin-2 production by undifferentiated memory T helper cells and extensive B cell clonal expansion |
Controlled access users
No use of the controlled access data has been recorded.